{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:06:55Z","timestamp":1792415215796,"version":"4.4.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Primary adenosquamous carcinoma (ASC) is a rare liver malignancy with very little data published so far. We describe the clinical characteristics of this tumor and analyze its survival pattern to improve the diagnosis and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>This study collected data of 15 patients with primary hepatic ASC in our hospital within 10 years (from 2009 to 2018). We analyzed the clinical characteristics, imaging data, treatment, and survival of ASC in the study. Two of these cases have been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The common clinical symptoms of hepatic ASC are liver pain and jaundice. Laboratory examination showed that carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) increased, but Alpha-FetoProtein (AFP) did not. Primary hepatic ASC is a rare subtype of intrahepatic cholangiocarcinoma (ICC) and meets the requirements of pathological diagnosis: CK20 (-), CK7 (+), CK19 (+), and p63 (+). Of the 15 patients, 11 were treated surgically, of which 3 patients received adjuvant chemotherapy. The prognosis of ASC patients is poor with a median survival time (MST) of 6 months (range: 2 to 15). The duration of MST in surgically treated patients was longer than that of nonsurgical patients (7.0 months <jats:italic>vs.<\/jats:italic> 3.0 months). Patients that received adjuvant chemotherapy survived longer (MST: 15 months). Patients with lymph node metastasis had a worse prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Primary hepatic ASC is a rare malignant tumor with a poor prognosis. Radical surgery may be an effective treatment for prolonging survival. Surgical treatment combined with adjuvant therapy may further improve survival.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.621594","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:13:52Z","timestamp":1628486032000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Qiheng","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengya","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6585-0","article-title":"Adenosquamous Carcinoma of the Liver: Clinicopathologic Study of 10 Surgically Treated Cases","volume":"27","author":"Yeh","year":"2003","journal-title":"World J Surg"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/56.6.758","article-title":"Mucoepidermoid Carcinoma of the Liver","volume":"56","author":"Pianzola","year":"1971","journal-title":"Am J Clin Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<364::AID-CNCR3>3.0.CO;2-S","article-title":"Adenosquamous Carcinoma of the Liver: Clinicopathologic Characteristics and Cytokeratin Profile","volume":"80","author":"Maeda","year":"1997","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2016.0077","article-title":"Primary Adenosquamous Carcinoma of the Liver: A Case Report","volume":"22","author":"Nam","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"B5","article-title":"Primary Adenosquamous Carcinoma of the Liver: A Case Report and Review of the Literature","volume":"8","author":"Gao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B6","article-title":"Primary Adenosquamous Carcinoma of the Liver Presenting With Hematochezia Due to Tumor Invasion of the Colon. Nihon Shokakibyo Gakkai Zasshi","volume":"110","author":"Takeda","year":"2013","journal-title":"Japanese J Gastro-enterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.845","article-title":"Preoperative Carbohydrate Antigen 19-9 and Standard Uptake Value of Positron Emission Tomography-Computed Tomography as Prognostic Markers in Patients With Pancreatic Ductal Adenocarcinoma","author":"Moon","year":"2020","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000180805.56952.04","article-title":"Primary Adenosquamous Carcinoma of the Liver: Case With the Longest Survival","volume":"39","author":"Demir","year":"2005","journal-title":"J\u00a0Clin Gstroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5833\/jjgs.35.1803","article-title":"A Resected Case of Primary Adenosquamous Carcinoma of the Liver","volume":"35","author":"Ono F","year":"2002","journal-title":"Jpn J Gastroenterol Surg"},{"key":"B10","article-title":"A Rare Case of Adenosquamous Carcinoma in the Liver With Hepatolithiasis","volume":"46","author":"Harino","year":"2019","journal-title":"Gan to kagaku ryoho Cancer Chemother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90084-5","article-title":"Combined Hepatocellular and Cholangiocarcinoma: Proposed Criteria According to Cytokeratin Expression and Analysis of Clinicopathologic Features","volume":"26","author":"Maeda","year":"1995","journal-title":"Hum Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000165705.74079.fc","article-title":"A Clinicopathologic Study of Primary Adenosquamous Carcinoma of the Liver","volume":"39","author":"Kobayashi","year":"2005","journal-title":"J Clin Gstroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i14.1653","article-title":"Update on Hepatocellular Carcinoma: Pathologists\u2019 Review","volume":"25","author":"El Jabbour","year":"2019","journal-title":"World J Gstroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(85)80234-3","article-title":"Squamous Cell Carcinoma of the Liver","volume":"16","author":"Gresham","year":"1985","journal-title":"Hum Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711070211","article-title":"Primary Squamous-Cell Carcinoma Arising in a Solitary non-Parasitic Cyst of the Liver","volume":"107","author":"Greenwood","year":"1972","journal-title":"J Pathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.14701\/kjhbps.2013.17.1.38","article-title":"A Case of Primary Adenosquamous Carcinoma of the Liver","volume":"17","author":"Kang","year":"2013","journal-title":"Korean J Hepato-Biliary-Pancreat Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2001.01302.x","article-title":"Double Cancer Consisting of Adenosquamous and Hepatocellular Carcinomas of the Liver","volume":"51","author":"Zhang","year":"2001","journal-title":"Pathol Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s005340200108","article-title":"Primary Adenosquamous Carcinoma of the Liver: Case Report","volume":"9","author":"Suzuki","year":"2002","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0019","article-title":"Guidelines Insights: Hepatobiliary Cancers, Version 2.2019","volume":"17","author":"Benson","year":"2019","journal-title":"J Natl Compr Cancer Netw: JNCCN"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.621594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T05:14:00Z","timestamp":1628486040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.621594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":19,"alternative-id":["10.3389\/fonc.2021.621594"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.621594","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"621594"}}